This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
USCAP 2022: The first-ever validation and deployment of AI-solution for gastric cancer detection
23 Mar, 2022
Back
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
Back
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis.
Our AI platform is deployed worldwide, supporting pathologists and providers with
AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis.
Our AI platform is deployed worldwide, supporting pathologists and providers with
AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.